Charles (Chuck) Larsen provides clients sophisticated multijurisdictional counsel in intellectual property portfolio strategy, including patent prosecution, transactions, and disputes, with a particular emphasis in bio medical engineering and life sciences. He is licensed to practice before the US Patent and Trademark Office (USPTO), the European Patent Office (EPO), and the courts of England and Wales.
He has extensive experience in transactional IP matters, including transaction structuring and portfolio due diligence for investments and acquisitions, and negotiating collaboration license agreements, joint ventures, and other strategic commercial contracts involving key IP assets.
He also actively supports and counsels on transatlantic disputes, including US District Court cases, Patent Trial and Appeal Board (PTAB) proceedings, Reexaminations, EPO Oppositions, and litigation in Europe’s Unified Patent Court.
Chuck has advised on a wide range of technology in engineering and life sciences, including medical technology, pharmaceuticals, microfluidics, drug delivery, machine learning, signal processing, combustion, and energy. In the medical technology sector, his experience has involved a wide range of technologies, including medical diagnostics, intravascular devices, respiratory systems, orthopedic implants, cellular therapy, tissue engineering, neuromonitoring, spine technology, electrical stimulation, healthcare informatics, DNA sequencing, software driven devices, and biologic manufacturing.
